Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

PHASE2CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

March 11, 2014

Primary Completion Date

May 3, 2018

Study Completion Date

October 28, 2020

Conditions
Urothelial Cancer
Interventions
DRUG

Nab-Paclitaxel

DRUG

Paclitaxel

Trial Locations (37)

2031

Prince of Wales Hospital, Sydney

2139

Concord Cancer Centre, Sydney

2170

Liverpool Hospital, Sydney

2444

Port Macquarie Base Hospital, Port Macquarie

3021

Western Hospital (renamed to Footscray Hospital), St Albans

3065

St Vincents Hospital Melbourne, Fitzroy

3121

Epworth Healthcare Freemasons Hospital, Richmond

3128

Box Hill Hospital, Box Hill

3199

Frankston Hospital, Frankston

Peninsula Oncology Centre, Frankston

3320

University Hospital Geelong, Geelong

3690

Border Medical Oncology (Murray Valley Private Hospital), Wodonga

4560

Nambour General Hospital, Nambour

4814

Townsville Hospital, Douglas

5037

Ashford Cancer Care Research, Kurralta Park

5042

Flinders Medical Centre, Bedford Park

6150

Royal Perth Hospital (renamed to Fiona Stanley Hospital), Perth

7000

Royal Hobart Hospital, Hobart

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

B3H 1V7

QEII Health Sciences Centre, Halifax

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N6A 5W9

London Regional Cancer Program, London

L3Y 2P9

Stronach Regional Health Centre at Southlake, Newmarket

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

M5G 2M9

University Health Network, Toronto

J4V 2H1

Hopital Charles LeMoyne, Greenfield Park

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H3T 1E2

The Jewish General Hospital, Montreal

H4A 3J1

The Research Institute of the McGill University, Montreal

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

G8Z 3R9

Centre hospitalier regional de Trois-Rivieres, Trois-Rivières

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

OTHER

collaborator

Celgene

INDUSTRY

lead

Canadian Cancer Trials Group

NETWORK